Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3244.5
(0.37%)
INR 3244.5
(0.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 21.42 Billion INR | -40.17% |
| 2022 | 44.95 Billion INR | 9.34% |
| 2021 | 41.11 Billion INR | 7.41% |
| 2020 | 38.28 Billion INR | -4.5% |
| 2019 | 40.08 Billion INR | 6.29% |
| 2018 | 37.71 Billion INR | 21.37% |
| 2017 | 31.07 Billion INR | 15.1% |
| 2016 | 26.99 Billion INR | 15.42% |
| 2015 | 23.39 Billion INR | 2.82% |
| 2014 | 22.74 Billion INR | 27.48% |
| 2013 | 17.84 Billion INR | 22.76% |
| 2012 | 14.53 Billion INR | 16.05% |
| 2011 | 12.52 Billion INR | 27.88% |
| 2010 | 9.79 Billion INR | 9.04% |
| 2009 | 8.98 Billion INR | 2.55% |
| 2008 | 8.75 Billion INR | 23.02% |
| 2007 | 7.11 Billion INR | -24.29% |
| 2006 | 9.4 Billion INR | 74.93% |
| 2005 | 5.37 Billion INR | 79.82% |
| 2004 | 2.98 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.11 Billion INR | 2.01% |
| 2024 Q2 | 14.12 Billion INR | 2.53% |
| 2023 Q2 | 13.44 Billion INR | 3.54% |
| 2023 Q3 | 13.38 Billion INR | -0.45% |
| 2023 Q1 | 12.98 Billion INR | 16.0% |
| 2023 FY | 26.9 Billion INR | -40.17% |
| 2023 Q4 | 6.97 Billion INR | -47.91% |
| 2022 Q4 | 11.18 Billion INR | -6.6% |
| 2022 Q3 | 11.98 Billion INR | 8.51% |
| 2022 FY | 44.95 Billion INR | 9.34% |
| 2022 Q1 | 10.75 Billion INR | 8.26% |
| 2022 Q2 | 11.04 Billion INR | 2.7% |
| 2021 FY | 41.11 Billion INR | 7.41% |
| 2021 Q2 | 10.16 Billion INR | -0.39% |
| 2021 Q1 | 10.2 Billion INR | 11.77% |
| 2021 Q3 | 10.83 Billion INR | 6.59% |
| 2021 Q4 | 9.92 Billion INR | -8.31% |
| 2020 Q3 | 9.7 Billion INR | 0.94% |
| 2020 Q4 | 9.12 Billion INR | -5.92% |
| 2020 FY | 38.28 Billion INR | -4.5% |
| 2020 Q2 | 9.61 Billion INR | -1.84% |
| 2020 Q1 | 9.79 Billion INR | 6.92% |
| 2019 Q2 | 10.52 Billion INR | 1.54% |
| 2019 FY | 40.08 Billion INR | 6.29% |
| 2019 Q3 | 10.05 Billion INR | -4.47% |
| 2019 Q1 | 10.36 Billion INR | 19.01% |
| 2019 Q4 | 9.15 Billion INR | -8.89% |
| 2018 Q3 | 9.63 Billion INR | -2.63% |
| 2018 Q2 | 9.89 Billion INR | 4.21% |
| 2018 FY | 37.71 Billion INR | 21.37% |
| 2018 Q4 | 8.7 Billion INR | -9.61% |
| 2018 Q1 | 9.49 Billion INR | -1.35% |
| 2017 Q4 | 9.62 Billion INR | 23.81% |
| 2017 FY | 31.07 Billion INR | 15.1% |
| 2017 Q3 | 7.77 Billion INR | 7.02% |
| 2017 Q2 | 7.26 Billion INR | 1.11% |
| 2017 Q1 | 7.18 Billion INR | 21.9% |
| 2016 Q1 | 7.07 Billion INR | 10.12% |
| 2016 FY | 26.99 Billion INR | 15.42% |
| 2016 Q4 | 5.89 Billion INR | -16.57% |
| 2016 Q3 | 7.06 Billion INR | -5.11% |
| 2016 Q2 | 7.44 Billion INR | 5.23% |
| 2015 Q1 | 5.38 Billion INR | -31.97% |
| 2015 Q3 | 5.32 Billion INR | -3.62% |
| 2015 Q4 | 6.42 Billion INR | 20.68% |
| 2015 FY | 23.39 Billion INR | 2.82% |
| 2015 Q2 | 5.52 Billion INR | 2.6% |
| 2014 Q4 | 7.9 Billion INR | 48.37% |
| 2014 Q2 | 5.33 Billion INR | 27.51% |
| 2014 FY | 22.74 Billion INR | 27.48% |
| 2014 Q1 | 4.18 Billion INR | -4.85% |
| 2014 Q3 | 5.33 Billion INR | 0.0% |
| 2013 Q2 | 4.68 Billion INR | 14.43% |
| 2013 Q4 | 4.39 Billion INR | -6.13% |
| 2013 FY | 17.84 Billion INR | 22.76% |
| 2013 Q3 | 4.68 Billion INR | 0.0% |
| 2013 Q1 | 4.09 Billion INR | 22.73% |
| 2012 Q3 | 3.72 Billion INR | -3.13% |
| 2012 Q2 | 3.84 Billion INR | 4.92% |
| 2012 FY | 14.53 Billion INR | 16.05% |
| 2012 Q1 | 3.66 Billion INR | 44.69% |
| 2012 Q4 | 3.33 Billion INR | -10.42% |
| 2011 Q3 | 3.36 Billion INR | 0.0% |
| 2011 FY | 12.52 Billion INR | 27.88% |
| 2011 Q4 | 2.52 Billion INR | -24.92% |
| 2010 FY | 9.79 Billion INR | 9.04% |
| 2009 FY | 8.98 Billion INR | 2.55% |
| 2008 FY | 8.75 Billion INR | 23.02% |
| 2007 FY | 7.11 Billion INR | -24.29% |
| 2006 FY | 9.4 Billion INR | 74.93% |
| 2005 FY | 5.37 Billion INR | 79.82% |
| 2004 FY | 2.98 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -34.987% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 45.401% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -84.028% |
| Granules India Limited | 7.18 Billion INR | -198.259% |
| Indoco Remedies Limited | 4.74 Billion INR | -351.108% |
| Achyut Healthcare Limited | 1.6 Million INR | -1331292.169% |
| Ajanta Pharma Limited | 30.46 Billion INR | 29.678% |
| Alkem Laboratories Limited | 32.83 Billion INR | 34.758% |
| Alpa Laboratories Limited | 156.14 Million INR | -13619.188% |
| Brooks Laboratories Limited | 51.18 Million INR | -41756.389% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -723.8% |
| Bajaj HealthCare Limited | 985.34 Million INR | -2074.071% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -1409.426% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 77.657% |
| Eris Lifesciences Limited | 4.94 Billion INR | -333.388% |
| FDC Limited | 5.34 Billion INR | -300.523% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 68.294% |
| Gufic Biosciences Limited | 1.07 Billion INR | -1887.741% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -908.486% |
| Ipca Laboratories Limited | 13.91 Billion INR | -53.951% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -2669.825% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -46312.384% |
| Lasa Supergenerics Limited | 291.17 Million INR | -7257.147% |
| Laurus Labs Limited | 3.01 Billion INR | -611.509% |
| Lupin Limited | 95.67 Billion INR | 77.609% |
| Mankind Pharma Limited | 23.15 Billion INR | 7.475% |
| Medicamen Biotech Limited | 335.16 Million INR | -6291.471% |
| Medico Remedies Limited | 161.84 Million INR | -13136.265% |
| Megasoft Limited | 49.52 Million INR | -43152.505% |
| NATCO Pharma Limited | 10.05 Billion INR | -112.986% |
| Piramal Pharma Limited | 19.91 Billion INR | -7.573% |
| RPG Life Sciences Limited | 1.63 Billion INR | -1209.82% |
| Sigachi Industries Limited | 579.88 Million INR | -3594.185% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 86.106% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -1427.108% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -2173.145% |
| Unichem Laboratories Limited | 6.72 Billion INR | -218.503% |
| Wanbury Limited | 1.16 Billion INR | -1745.258% |
| Windlas Biotech Limited | 1 Billion INR | -2028.354% |
| ZIM Laboratories Limited | 1.01 Billion INR | -2014.598% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 50.382% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -596.246% |
| Divi's Laboratories Limited | 14.17 Billion INR | -51.179% |
| Hester Biosciences Limited | 908.84 Million INR | -2257.082% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -615.167% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -1849.257% |
| Bal Pharma Limited | 389.89 Million INR | -5394.396% |
| Strides Pharma Science Limited | 9.16 Billion INR | -133.807% |
| Venus Remedies Limited | 1.91 Billion INR | -1017.898% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -596.79% |
| Nectar Lifesciences Limited | 625.55 Million INR | -3324.522% |
| Shilpa Medicare Limited | 2.18 Billion INR | -882.4% |
| Aarti Drugs Limited | 1.16 Billion INR | -1734.902% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -1849.59% |
| Suven Life Sciences Limited | 109.75 Million INR | -19418.998% |
| Ind-Swift Limited | 946.56 Million INR | -2163.136% |
| Valiant Laboratories Limited | 36.28 Million INR | -58931.938% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -154.508% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -367.762% |
| Themis Medicare Limited | 782.85 Million INR | -2636.407% |
| Hikal Limited | 2.48 Billion INR | -761.592% |
| Sequent Scientific Limited | 2.9 Billion INR | -638.232% |
| Novartis India Limited | 470.1 Million INR | -4456.924% |
| Wockhardt Limited | 6.4 Billion INR | -234.72% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -48.209% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -132056.063% |
| Neuland Laboratories Limited | 2.92 Billion INR | -631.193% |
| Morepen Laboratories Limited | 1.98 Billion INR | -977.869% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -5094.156% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -3068.261% |